CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-21 | Powell Lynne Senior VP - CCO | Option exercise | +12,000 | $3.22 | $39K | 14,455 |
| 2018-11-21 | Powell Lynne Senior VP - CCO | Sale | −12,000 | $9.06 | $109K | 2,455 |
| 2018-11-21 | Powell Lynne Senior VP - CCO | Sale | −2,455 | $9.01 | $22K | 0 |
| 2018-11-21 | Powell Lynne Senior VP - CCO | Option exercise · Emp. Stock Option (Right to Buy) | −12,000 | 101,427 | ||
| 2018-11-21 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +5,000 | $5.45 | $27K | 142,383 |
| 2018-11-21 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −5,000 | $9.41 | $47K | 137,383 |
| 2018-11-21 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +7,000 | $3.78 | $26K | 144,383 |
| 2018-11-21 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −7,000 | $9.08 | $64K | 137,383 |
| 2018-11-21 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −5,000 | 12,000 | ||
| 2018-11-21 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −7,000 | 31,805 | ||
| 2018-11-20 | Powell Lynne Senior VP - CCO | Option exercise | +9,127 | $3.22 | $29K | 17,732 |
| 2018-11-20 | Powell Lynne Senior VP - CCO | Sale | −9,127 | $8.52 | $78K | 8,605 |
| 2018-11-20 | Powell Lynne Senior VP - CCO | Sale | −6,150 | $8.61 | $53K | 2,455 |
| 2018-11-20 | Powell Lynne Senior VP - CCO | Option exercise · Emp. Stock Option (Right to Buy) | −9,127 | 113,427 | ||
| 2018-11-20 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +4,623 | $3.78 | $17K | 142,006 |
| 2018-11-20 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −4,623 | $8.57 | $40K | 137,383 |
| 2018-11-20 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +6,500 | $3.22 | $21K | 143,883 |
| 2018-11-20 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −6,500 | $8.75 | $57K | 137,383 |
| 2018-11-20 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −4,623 | 38,805 | ||
| 2018-11-20 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −6,500 | 97,071 |
Page 33 of 38 · 750 trades